Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
Teladoc HealthTDOC |
39,071 0% |
 |
Veeva SystemsVEEV |
8,760 0% |
 |
DoximityDOCS |
3,480 0.1% |
 |
Lifestance HealthLFST |
486 0.2% |
 |
AmwellAMWL |
3,580 0% |
Month over Month
Subscribing Stocktwits Users
| Oct 2024 | 5,562 | |
| Sep 2024 | 5,576 | |
| Aug 2024 | 5,584 | |
| Jul 2024 | 5,596 | |
| Jun 2024 | 5,599 |
How many users are following GoodRx on StockTwits?
The interest in GoodRx on StockTwits is minor, with a following of 5,644 investors.
Analyzing Stocktwits Subscribers, how is GoodRx performing compared to its industry peers?
GoodRx underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 14th percentile.
What has been the change in GoodRx's StockTwits followers over the past month?
The number of Ford followers on StockTwits has decreased by 0.2% in the last month. For investors, this change could indicate a shift in market sentiment or reaction to recent developments. It's important to analyze this trend in the context of other market indicators and GoodRx's overall performance to understand its implications fully.
What is StockTwits?
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Why is it important for GoodRx investors to monitor its StockTwits followers?
For investors in GoodRx, tracking the number of followers on StockTwits can be highly beneficial. The platform's follower count offers a direct gauge of investor interest and sentiment surrounding Ford. An increasing follower count typically suggests growing investor attention and can be an indicator of rising market enthusiasm or concern about the company's prospects. This data can provide investors with valuable insights into market trends, potential shifts in investor behavior, and broader perceptions of Ford in the investment community.
Sign up and get more insights on GoodRx.
